Entry Decisions in the Generic Pharmaceutical Industry

Fiona M. Scott Morton ()
Additional contact information
Fiona M. Scott Morton: School of Management

Yale School of Management Working Papers from Yale School of Management

Abstract: Data on all generic drug entries in the period 1984-1994 are used to estimate which markets heterogeneous potential entrants will decide to enter. I find that organizational experience predicts entry. Firms tend to enter markets with supply and demand characteristics similar to the firm's existing drugs. Larger revenue markets, markets with more hospital sales, and products that treat chronic conditions attract more entry. The simultaneous nature of entry leads to an additional interpretation: specialization is profitable because of the severe risk to profits when a market is "overentered." However, I am unable to make any conclusions about the efficiency of entry decisions.

JEL-codes: L0 L81 (search for similar items in EconPapers)
Date: 1999-06-16
References: Add references at CitEc
Citations: View citations in EconPapers (79)

Downloads: (external link)
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=164431 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ysm:somwrk:ysm119

Access Statistics for this paper

More papers in Yale School of Management Working Papers from Yale School of Management Contact information at EDIRC.
Bibliographic data for series maintained by ().